Curis

is a Massachusetts-based biotechnology company that develops and commercializes innovative therapeutics for the treatment of cancer...
Read more
Curis President & CEO: James E. Dentzer

President & CEO

James E. Dentzer

CEO Approval Rating

96/100

2000

PublicIndependent CompanyNASDAQCRIS

28362834 NAICS listing
Annual Revenue
$10.9M
Employees
60
Funding
$121.3M
Acquisitions
1

Curis Competitors

1Emmaus
2Kurome Therapeutics
3Kymera
4Rigel Pharmaceuticals
5Apexigen
6Kineta
7PharmAbcine
8Sensei Bio
9Regeneron
10Incyte

Trending Companies